TripSitter Clinic Ltd. KETA

Company Overview

TripSitter Clinic Ltd. (NASDAQ: KETA) is a healthcare and telemedicine-focused company operating in the mental health and psychedelic-assisted therapy sector. The company’s primary activities have centered on ketamine-assisted therapy, psychiatric care, and digital healthcare delivery, with a focus on treatment-resistant mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Public disclosures and market filings indicate that the company has pursued a clinic-enabled and telehealth-oriented care model designed to expand access to psychedelic-informed mental health treatment services in the United States.

The company’s revenue drivers have historically included patient treatment programs, psychiatric consultations, telemedicine services, and related healthcare offerings. Its strategic positioning has been tied to the growing interest in alternative mental health therapies and the broader behavioral health market. Based on available public filings and corporate disclosures, the company evolved through acquisitions and restructuring activities connected to the emerging psychedelic medicine industry. Certain historical operational details and financial scale metrics are not consistently reported across public sources; data is inconclusive based on available public sources.